Financial results - EXCLUSIVE PHARMA S.R.L.

Financial Summary - Exclusive Pharma S.r.l.
Unique identification code: 44560450
Registration number: J40/11792/2021
Nace: 4791
Sales - Ron
44.860
Net Profit - Ron
33.108
Employees
1
Open Account
Company Exclusive Pharma S.r.l. with Fiscal Code 44560450 recorded a turnover of 2024 of 44.860, with a net profit of 33.108 and having an average number of employees of 1. The company operates in the field of CAEN Ver.3: Intermedieri în comerţul cu amănuntul nespecializat; CAEN Ver.2: Comert cu amanuntul prin intermediul caselor de comenzi sau prin Internet; having the NACE code 4791.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Exclusive Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - 8.277 31.120 43.552 44.860
Total Income - EUR - - - - - - 8.277 31.120 43.552 44.860
Total Expenses - EUR - - - - - - 884 2.501 2.422 11.370
Gross Profit/Loss - EUR - - - - - - 7.393 28.619 41.130 33.490
Net Profit/Loss - EUR - - - - - - 7.150 27.768 35.812 33.108
Employees - - - - - - 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 3.6%, from 43.552 euro in the year 2023, to 44.860 euro in 2024. The Net Profit decreased by -2.503 euro, from 35.812 euro in 2023, to 33.108 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Exclusive Pharma S.r.l.

Rating financiar

Financial Rating -
EXCLUSIVE PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Exclusive Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Exclusive Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Exclusive Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Exclusive Pharma S.r.l. - CUI 44560450

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - 926 592 1.029 1.361
Current Assets - - - - - - 9.567 27.695 51.257 82.267
Inventories - - - - - - 0 0 0 0
Receivables - - - - - - 0 16.646 4.706 3.509
Cash - - - - - - 9.567 11.049 46.552 78.758
Shareholders Funds - - - - - - 7.191 27.817 49.760 82.591
Social Capital - - - - - - 40 41 40 40
Debts - - - - - - 3.303 469 2.526 1.037
Income in Advance - - - - - - 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4791 - 4791"
CAEN Financial Year 4791
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 82.267 euro in 2024 which includes Inventories of 0 euro, Receivables of 3.509 euro and cash availability of 78.758 euro.
The company's Equity was valued at 82.591 euro, while total Liabilities amounted to 1.037 euro. Equity increased by 33.108 euro, from 49.760 euro in 2023, to 82.591 in 2024.

Risk Reports Prices

Reviews - Exclusive Pharma S.r.l.

Comments - Exclusive Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.